MRI for men undergoing active surveillance or with rising PSA and negative biopsies
- 8 October 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Urology
- Vol. 7 (10), 543-551
- https://doi.org/10.1038/nrurol.2010.143
Abstract
Prostate cancer localization has been greatly improved by the emergence of 3T and multiparametric MRI technologies. Raz et al. provide a clear and comprehensive description of the MRI sequences that can be used to detect prostate tumors before focusing on the patient populations that might benefit most from these technical advances. The role of imaging in treatment decision-making for patients with prostate cancer is to characterize the cancer already diagnosed on biopsy, to determine tumor location, to assess tumor volume, and to exclude more-extensive disease. MRI is currently the most established imaging modality for this purpose, with the highest sensitivity and specificity for detection and staging of prostate tumors. The development and wider adoption of active surveillance and focal treatment approaches would also benefit from accurate localization of cancer. As such, 3 T MRI and multiparametric approaches are being developed as tools for the localization and staging of prostate cancer. Men wishing to commence or remain on active surveillance might benefit by having larger cancers identified before embarking on this management strategy. MRI might have its greatest role in patients where there is a discrepancy between PSA and biopsy results suggesting a potential missed prostate tumor.Keywords
This publication has 74 references indexed in Scilit:
- Prostate Cancer: Value of Multiparametric MR Imaging at 3 T for Detection—Histopathologifc CorrelationRadiology, 2010
- Focal Treatment or Observation of Prostate Cancer: Pretreatment Accuracy of Transrectal Ultrasound Biopsy and T2-weighted MRIUrology, 2010
- Integrated navigation and control software system for MRI-guided robotic prostate interventionsComputerized Medical Imaging and Graphics, 2010
- Prostate Tumor Volume Measurement with Combined T2-weighted Imaging and Diffusion-weighted MR: Correlation with Pathologic Tumor VolumeRadiology, 2009
- Prostate Cancer: Sextant Localization at MR Imaging and MR Spectroscopic Imaging before Prostatectomy—Results of ACRIN Prospective Multi-institutional Clinicopathologic StudyRadiology, 2009
- Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissuesMagnetic Resonance Imaging, 2008
- Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological studyThe Lancet Oncology, 2008
- Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975–2004BJU International, 2008
- Multiparametric magnetic resonance imaging in prostate cancer: present and futureCurrent Opinion in Urology, 2008
- Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissueJournal of Magnetic Resonance Imaging, 2004